NCT01228370View on ClinicalTrials.gov

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

PHASE4CompletedINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

January 31, 2012

Study Completion Date

January 31, 2012

Conditions
Neurogenic BladderVoiding Dysfunction
Interventions
DRUG

silodosin

silodosin 8mg once a day for 12 weeks

Trial Locations (6)

Unknown

Daegu Catholic Univ. Medical Center, Daegu

Daegu Fatima Hospital, Daegu

Keimyung Univ. Dongsan Medical Center, Daegu

Yeungnam Univ. Medical Center, Daegu

Samsung Changwon Hospital, Changwon

Ulsan Univ. Hospital, Ulsan

Sponsors

Lead Sponsor

JW Pharmaceutical
All Listed Sponsors
lead

JW Pharmaceutical

INDUSTRY